Broadfin Capital Stake in Adma Biologics (ADMA) Cut by $475,504; Mangrove Partners Upped Its Ani Pharmaceuticals (ANIP) Holding by $1.67 Million; Market Valuation Rose - Standard Recorder

Broadfin Capital Stake in Adma Biologics (ADMA) Cut by $475,504; Mangrove Partners Upped Its Ani Pharmaceuticals (ANIP) Holding by $1.67 Million; Market Valuation Rose  Standard Recorder

Broadfin Capital Llc decreased its stake in Adma Biologics Inc (ADMA) by 5.33% based on its latest 2018Q4 regulatory filing with the SEC. Broadfin Capital Llc ...

from "mangroves" - Google News https://ift.tt/2H4I1GN
via IFTTT